Physician profile
Eric Rottenberg
NPI 1598793713
$3,609.84
in general payments reported to CMS, 2019-2025
33 companies · $45.32 in 2025
The $45.32 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $436 · 2021: $1,113 · 2022: $816 · 2023: $789 · 2024: $98.45 · 2025: $45.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $567.40 | 2020-2023 | Xtandi |
| Abbvie INC. | $340.80 | 2020-2025 | Botox, Lupron Depot |
| Teleflex LLC | $304.07 | 2021-2023 | Urolift |
| Janssen Biotech, INC. | $282.96 | 2020-2023 | Erleada |
| Antares Pharma, INC. | $207.96 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Gilead Sciences, INC. | $189.62 | 2019 | |
| Urovant Sciences INC | $156.93 | 2021-2022 | |
| Axonics, INC. | $133.58 | 2020-2023 | Axonics |
| Allergan, INC. | $121.10 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $119.69 | 2021-2024 | Prolaris |
| Boston Scientific Corporation | $117.10 | 2021-2023 | Spaceoar Vue System - 10ml, Rezum Generator |
| 180 Medical, INC. | $109.55 | 2021-2023 | Speedicath |
| Amgen INC. | $91.12 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $83.64 | 2022-2024 | Keytruda, Lynparza |
| Tolmar Pharmaceuticals, INC. | $81.57 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $77.70 | 2021-2022 | |
| Lilly USA, LLC | $76.61 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.18 | 2023-2024 | |
| Blue Earth Diagnostics | $64.32 | 2020-2021 | |
| Urogen Pharma, INC. | $55.43 | 2023 | Jelmyto |
| Halozyme INC | $49.74 | 2023 | |
| Coloplast Corp | $45.76 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $35.62 | 2023 | Gemtesa |
| Pfizer INC. | $35.25 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $33.39 | 2020-2022 | |
| Medtronic, INC. | $24.93 | 2023 | Interstim |
| Amarin Pharma, INC. | $24.62 | 2019 | |
| Dentsply Ih Ab | $19.98 | 2023 | Lofric |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.53 | 2019 | |
| Clarus Therapeutics INC. | $18.93 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.23 | 2023 | Seglentis |
| Novartis Pharmaceuticals Corporation | $15.46 | 2023 | |
| Progenics Pharmaceuticals, INC. | $14.07 | 2023 | Pylarify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rottenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.